ESMO22 Highlights: Patient Advocacy

Published 2022-09-15

Recommendations

06:04

Dr. Toni Choueiri Discusses Belzutifan's FDA Approval: A Game-Changer for Clear Cell Kidney Cancer
02:23

What is Advocacy? | Advocacy Training for CHWs
01:37

ESMO22 Highlights: Dr. Jonasch Discusses the COSMIC313 Trial for Kidney Cancer
06:33

One Kidney Cancer's Patient's Journey with Belzutifan: From Clinical Trial to FDA Approval
12:51

My Renal Artery Dissection and Kidney Infarction with VEDS (Vascular Ehlers-Danlos Syndrome)
1:49:52

Clery Handbook Highlights - Webinar
1:02:06

Understanding Clinical Trials for Kidney Cancer: Expert & Patient Insights | KidneyCAN Town Hall
1:05:16

Protecting the Legitimacy of Medical Expertise: Combating Misinformation in Medicine
05:39

Immunotherapy Breakthroughs in Kidney Cancer: KCRS Insights with Dr. David Braun from Yale
18:40

Matthew Perry's Death From Ketamine Explained (Is It Safe For You?)
34:11

WEBINAR: HPV, Abnormal Pap Smears, Cervical Cancer and the HPV Vaccine
22:14

What they don't tell you about cannabis before surgery- Dr. Kaveh LIVE
05:17

GS#092 Traditional Easter visit to A&E
33:51

After Kidney Cancer Treatment: What You Need to Know
21:52

Clery Center Conversations: FAQs on the 2016 Handbook Rescission and Replacement
59:42

2024 Kidney Cancer Research Insights: KidneyCAN Town Hall with Leading Experts The Uromigos
53:35

All You Need to Know to be a Competitive MD PhD Applicant
04:00

Advancing Kidney Cancer Treatment: Dr. Hans Hammers and Patient Gary Cole on Clinical Trials
56:50

Dr. Daniel Weintraub - Cognitive Complications in Parkinson's
02:04

KCRS23 Meeting Insights: A Patient & Researcher Perspective with Dr. Adam Stern & Dr. Toni Choueiri

Similar videos